… and down‐regulated by anti‐inflammatory and immunomodulatory agents, including statins,
fibrates, and glitazones. These agents also help reverse the mitochondrial dysfunction that …

… features of 18 cases of immunomodulator agent-related lymphoproliferative … case series
illustrates that a broad range of lymphoid proliferations can occur after immunomodulator agent …

… into two types: those with mild cases, which can be quickly controlled or self-limiting, and
those with severe cases, which often progress to severe or critical illness and can be life-…

… Here we review the efficacy and side effects of immunomodulatory therapies commonly …
of autoimmune etiology) discussed in this review, evidence is limited to small case series. …

… In the interim, a case report published in September 2020 provides the first promising data …
In addition, a case-control study of over 6,000 patients with severe COVID-19 also suggested …

… Tacrolimus: Tacrolimus is another immunomodulatory agent occasionally used in cases
of intermediate uveitis, posterior uveitis, and panuveitis. It was shown to suppress MERS-CoV …

… The rational use of immunomodulatory agents requires a … Immunomodulatory agents have
the ability to act at different … monotherapy continued • In cases of more severe clinical disease, …

… In the most severe cases, the so-called “cytokine storm” develops, characterized by increased
production of cytokines that produce long-term damage and fibrosis of lung tissues [13]. …

… Severe systemic inflammation associated with some stages of COVID-19 and in fatal cases
led therapeutic agents … in combination with other immunomodulatory agents) that require to …

… , one pouchitis) and severe activity according to the Truelove and … Moreover, a rectovaginal
fistula closure in a case of Crohn’s … bowel disease in the majority of cases. It appears to be an …